LOS ANGELES – Upheaval in Washington is creating an unpredictable path forward for innovation and investment in the biopharmaceutical industry, attendees said at a roundtable discussion on May 4.

Integration, high-quality management teams and alignment among stakeholders are key components of a rewarding deal, speakers said at a virtual Axios event on June 11. Axios' Lucinda Shen and George ...